Corient Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721M | Buy |
1,752,607
+825,649
| +89% | +$339M | 0.76% | 22 |
|
|
2025
Q1 | $461M | Buy |
926,958
+31,031
| +3% | +$15.4M | 0.75% | 22 |
|
|
2024
Q4 | $465M | Sell |
895,927
-54,001
| -6% | -$28.1M | 0.77% | 19 |
|
|
2024
Q3 | $588M | Buy |
949,928
+23,467
| +3% | +$14.5M | 0.92% | 19 |
|
|
2024
Q2 | $512M | Sell |
926,461
-13,331
| -1% | -$7.37M | 0.89% | 18 |
|
|
2024
Q1 | $546M | Sell |
939,792
-3,762
| -0.4% | -$2.19M | 0.97% | 13 |
|
|
2023
Q4 | $501M | Buy |
943,554
+124,673
| +15% | +$66.2M | 0.92% | 16 |
|
|
2023
Q3 | $414M | Sell |
818,881
-9,704
| -1% | -$4.91M | 0.95% | 17 |
|
|
2023
Q2 | $432M | Buy |
828,585
+20,751
| +3% | +$10.8M | 1% | 15 |
|
|
2023
Q1 | $466M | Buy |
807,834
+195,489
| +32% | +$113M | 1.25% | 6 |
|
|
2022
Q4 | $337M | Buy |
+612,345
| New | +$337M | 1.22% | 8 |
|